Scandinavian Biolabs is a Copenhagen-based DTC hair loss brand founded in 2020, developing bio-optimised hair growth systems built on its proprietary Bio-Pilixin® formulation. The brand markets to men and women experiencing early-stage hair loss, positioning as a science-backed, drug-free alternative to minoxidil and finasteride. Backed by Auréa Group and Blazar Capital, it has scaled to 191,619 customers across Europe and the US, with retail presence in Boots, Douglas, Flaconi, and 50+ pharmacies.